Stefan Scherer

Company: 3T Biosciences

Job title: Chief Executive Officer

Seminars:

Breaking Down Solid Tumor Barriers with a Novel Bispecific T-Cell Engager Against a Novel pHLA Target 12:45 pm

• Leveraging the 3T-TRACE platform to screen TCR and TCR mimetic molecules for specific and off-target cross-reactivities • Building highly specific and safe TCRs for shared targets to effectively treat solid tumorsRead more

day: Day 1